相关实验视频
Updated: Jun 25, 2026

11:51
Facile Preparation of 4-Substituted Quinazoline Derivatives
Published on: February 15, 2016
12.4K
-6--4-基-2-诺-3-碳胺:合成,计算研究和生物研究作为抗癌剂
Sara Jamal Meknas1, Eveen Al-Shalabi1, Rima Hajjo1,2,3
1Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman 11733, Jordan.
Molecules (Basel, Switzerland)
|February 27, 2026
概括
研究人员合成了新的诺衍生物来对抗癌症. 特定的替代物对人类结肠癌细胞显示出显著的细胞毒性,这表明有可能开发新的抗癌药物.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 癌症研究 癌症研究
背景情况:
- 癌症是全球主要的死亡原因,需要新的治疗策略.
- 奎诺衍生物正在被研究其潜在的抗癌活性.
研究的目的:
- 为了合成和描述新的N--6--4-基-2-诺-3-碳胺衍生物.
- 评估这些化合物的细胞毒性与人类结直肠癌细胞系.
- 调查有希望的类型药物的药物相似性和结合相互作用.
主要方法:
- 合成了二十种诺衍生物.
- 光谱分析 (FT-IR,NMR,元素分析).
- 在体外细胞毒性测定 (HCT-116,Caco-2细胞).
- 化学信息学和分子对接研究 (PI3Kα).
主要成果:
- 特定衍生物 (如8,10,18,19,21) 对HCT-116细胞表现出显著的细胞毒性 (IC50值为72.0-112.0μM).
- 化学信息学分析证实了有利的药物相似性和物理化学性质.
- 对接研究揭示了与PI3Kα的潜在结合相互作用,表明了一种作用机制.
结论:
- 合成的诺衍生物显示出作为抗癌剂的前途.
- 结构性修改可以增强细胞毒性和选择性.
- 这些化合物的进一步开发可能会导致针对特定途径的新型结直肠癌治疗方法.
相关概念视频
Radical Chain-Growth Polymerization: Overview
Chain-growth or addition polymerization is successive addition reactions of monomers with a polymer chain. In radical chain-growth polymerization, the reaction proceeds via a free-radical intermediate. The free radical is formed from radical initiators, which spontaneously generate free radicals by homolytic fission. Organic peroxides (such as dibenzoyl peroxide, as shown in Figure 1) or azo compounds are popular radical initiators. A low concentration ratio of radical initiator to monomer is...
Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...

